BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Criticare Systems, Inc. (CMD) Announces a Correction to the Preliminary, Unaudited Fiscal 2007 Fourth Quarter and Year End Net Sales Statement Issued July 26, 2007


9/24/2007 7:11:42 AM

MILWAUKEE--(BUSINESS WIRE)--CRITICARE SYSTEMS, INC. (AMEX:CMD). Criticare Systems, Inc. today announced a correction to the preliminary, unaudited net sales for the quarter and year ended June 30, 2007. It was determined on Thursday, September 20, 2007 that a $1,874,000 order by the ministry of health of the Republic of Iraq shipped in the fourth quarter of fiscal 2007, an order in which payment has been secured by a confirmed letter of credit, did not meet all the strict criteria for revenue recognition in accordance with SAB No. 104. Due to the size and risks associated with a contract of this nature, the Company obtained a confirmed letter of credit to secure payment. As a result, while the order met the revenue recognition criteria of ensuring collectibility, the terms of the letter of credit did not allow the transfer of title to occur until after June 30, 2007. The preliminary, unaudited fiscal fiscal 2007 fourth quarter and year end net sales previously stated on July 26, 2007 were $9,500,000 and $33,290,000, respectively. As a result of the revenue recognition criteria for this order not being met during the fourth quarter of fiscal 2007, the preliminary, unaudited fiscal 2007 fourth quarter and year end net sales will be reduced to $7,626,000 and $31,416,000, respectively. The majority of this sale will be included in the first quarter results for fiscal 2008.

Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->